101 related articles for article (PubMed ID: 16604825)
21. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food.
Kim TE; Kim JR; Jung JA; Kim MJ; Lee SY; Ko JW; Jung WT; Choi YW; Lee HJ; Kim SH; Huh W
J Clin Pharm Ther; 2014 Apr; 39(2):192-5. PubMed ID: 24325365
[TBL] [Abstract][Full Text] [Related]
22. Effects of sarpogrelate on serotonin-induced increases in cytosolic Ca2+ in cultured rat mesangial cells.
Kanamori A; Matoba K; Yajima Y
Life Sci; 1994; 55(18):PL365-70. PubMed ID: 7934648
[TBL] [Abstract][Full Text] [Related]
23. Sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, attenuates neurogenic pain induced by nucleus pulposus in rats.
Hashizume H; Kawakami M; Yoshida M; Okada M; Enyo Y; Inomata Y
Spine (Phila Pa 1976); 2007 Feb; 32(3):315-20. PubMed ID: 17268262
[TBL] [Abstract][Full Text] [Related]
24. Blockade of 5-HT(2A) receptors by sarpogrelate protects the heart against myocardial infarction in rats.
Brasil D; Temsah RM; Kumar K; Kumamoto H; Takeda N; Dhalla NS
J Cardiovasc Pharmacol Ther; 2002 Jan; 7(1):53-9. PubMed ID: 12000979
[TBL] [Abstract][Full Text] [Related]
25. Effect of sarpogrelate on altered STZ-diabetes induced cardiovascular responses to 5-hydroxytryptamine in rats.
Umrani DN; Bodiwala DN; Goyal RK
Mol Cell Biochem; 2003 Jul; 249(1-2):53-7. PubMed ID: 12956398
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate.
Sharma SK; Zahradka P; Chapman D; Kumamoto H; Takeda N; Dhalla NS
J Pharmacol Exp Ther; 1999 Sep; 290(3):1475-81. PubMed ID: 10454527
[TBL] [Abstract][Full Text] [Related]
27. The effect of a 5HT2 receptor antagonist sarpogrelate (MCI-9042) treatment on platelet function in Buerger's disease.
Rydzewski A; Urano T; Hachiya T; Kaneko H; Baba S; Takada Y; Takada A
Thromb Res; 1996 Dec; 84(6):445-52. PubMed ID: 8987165
[TBL] [Abstract][Full Text] [Related]
28. Sarpogrelate protects against high glucose-induced endothelial dysfunction and oxidative stress.
Sun YM; Su Y; Jin HB; Li J; Bi S
Int J Cardiol; 2011 Mar; 147(3):383-7. PubMed ID: 19883950
[TBL] [Abstract][Full Text] [Related]
29. Comparison of pharmacokinetics between sarpogrelate hydrochloride immediate-release formulation and controlled-release formulation.
Kim TE; Kim JR; Jung JA; Kim SR; Lee JW; Jun H; Lee SY; Huh W; Ko J
Int J Clin Pharmacol Ther; 2013 Feb; 51(2):114-9. PubMed ID: 23073143
[TBL] [Abstract][Full Text] [Related]
30. Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial.
Shinohara Y; Nishimaru K; Sawada T; Terashi A; Handa S; Hirai S; Hayashi K; Tohgi H; Fukuuchi Y; Uchiyama S; Yamaguchi T; Kobayashi S; Kondo K; Otomo E; Gotoh F;
Stroke; 2008 Jun; 39(6):1827-33. PubMed ID: 18388340
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery.
Nishihira K; Yamashita A; Tanaka N; Kawamoto R; Imamura T; Yamamoto R; Eto T; Asada Y
J Thromb Haemost; 2006 Jan; 4(1):247-55. PubMed ID: 16409475
[TBL] [Abstract][Full Text] [Related]
32. Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina.
Kajiwara I; Soejima H; Miyamoto S; Ogawa H
Thromb Res; 2011 Dec; 128(6):547-51. PubMed ID: 21722942
[TBL] [Abstract][Full Text] [Related]
33. Anplag, a selective 5-HT2 receptor antagonist, reduces stenosis induced by balloon injury in the hypercholesterolaemic rabbit.
Origuchi N; Shigematsu H; Muto T
Int Angiol; 1997 Sep; 16(3):204-9. PubMed ID: 9405017
[TBL] [Abstract][Full Text] [Related]
34. Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study.
Lee SA; Suh JW; Park JJ; Yoon CH; Cho YS; Youn TJ; Chae IH; Kim HS; Kim SH; Choi DJ
Contemp Clin Trials; 2015 Jul; 43():20-4. PubMed ID: 25891091
[TBL] [Abstract][Full Text] [Related]
35. Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia.
Higashi Y; Miyazaki M; Goto C; Sanada H; Sueda T; Chayama K
J Cardiovasc Pharmacol; 2010 Jan; 55(1):56-61. PubMed ID: 19834330
[TBL] [Abstract][Full Text] [Related]
36. The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients.
Ogawa S; Takeuchi K; Sugimura K; Sato C; Fukuda M; Lee R; Ito S; Sato T
Clin Exp Pharmacol Physiol; 1999; 26(5-6):461-4. PubMed ID: 10386239
[TBL] [Abstract][Full Text] [Related]
37. Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
Kauffman RF; Bean JS; Bloomquist WE; Cohen ML
J Pharmacol Exp Ther; 1993 Jul; 266(1):450-5. PubMed ID: 8331571
[TBL] [Abstract][Full Text] [Related]
38. Multiple-Dose Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety in Healthy Subjects: A Comparison of Controlled-Release Sarpogrelate and Immediate-Release Sarpogrelate.
Lee SY; Kim JR; Jung JA; Kim TE; Lee SY; Huh W; Lee JW; Jun H; Ko JW
Pharmacology; 2015; 96(1-2):68-75. PubMed ID: 26089136
[TBL] [Abstract][Full Text] [Related]
39. [Involvement of peripheral 5-HT2A receptor activation in inflammatory pain].
Nakanishi O; Ishikawa T
Nihon Rinsho; 2001 Sep; 59(9):1675-80. PubMed ID: 11554035
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Proteome Profiling of Platelet Identified a Protein Profile Predictive of Responses to An Antiplatelet Agent Sarpogrelate.
Lee H; Chae S; Park J; Bae J; Go EB; Kim SJ; Kim H; Hwang D; Lee SW; Lee SY
Mol Cell Proteomics; 2016 Nov; 15(11):3461-3472. PubMed ID: 27601597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
